Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01008670 · ClinicalTrials.gov registry record
Identification of the Pericardiophrenic Vein During Cardiac Device Implant Procedures to Prevent Extracardiac Stimulation
A clinical trial, sponsored by Respicardia.
- Completed
- Registry status
- 120
- Enrollment target
NCT01008670 is a clinical trial that has completed, run by Respicardia. The registered enrollment target is 120 participants.
The verdict
NCT01008670 has completed, sponsored by Respicardia.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
Study Summary
The primary goal of this study is to develop techniques to identify the course of the phrenic nerve in patients already undergoing cardiac resynchronization therapy (CRT) implantation or candidates for future CRT devices undergoing implantable cardioverter-defibrillator (ICD) or pacemaker implantation. Specifically, the study intends to identify the location and course of the left pericardiophrenic vein, and thus the left phrenic nerve, to guide the location for coronary vein lead placement and minimize the risk of phrenic nerve stimulation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2007-12 |
| Est. Completion | 2010-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01008670
The ClinicalTrials.gov registry entry for NCT01008670 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Respicardia, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01008670 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01008670 about?
NCT01008670 is a clinical study titled "Identification of the Pericardiophrenic Vein During Cardiac Device Implant Procedures to Prevent Extracardiac Stimulation". The primary goal of this study is to develop techniques to identify the course of the phrenic nerve in patients already undergoing cardiac resynchronization therapy (CRT) implantation or candidates for future CRT devices undergoing implantable cardioverter-defibrillator (ICD) or pacemaker implantati...
What is the current status of trial NCT01008670?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2007-12. Estimated completion is 2010-10.
Who is sponsoring clinical trial NCT01008670?
This trial is sponsored by Respicardia, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.